Página principal > Resultados de la búsqueda: Ward, Brian J.
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.01 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
18 p, 436.4 KB COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
Introduction: The SARS-CoV-2 pandemic necessitated better understanding of the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report characteristics of COVID-19 cases and vaccination status in ofatumumab-treated relapsing multiple sclerosis (RMS) patients. [...]
2022 - 10.1007/s40120-022-00341-z
Neurology and Therapy, Vol. 11 Núm. 2 (june 2022) , p. 741-758  
Registro completo - Creative Commons
2.
4 p, 243.1 KB Correction to : COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
2022 - 10.1007/s40120-022-00346-8
Neurology and Therapy, Vol. 11 Núm. 2 (2022) , p. 759-762  
Registro completo - Creative Commons

Vea también: autores con nombres similares
8 Ward, B.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos